TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 159 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $38,397,000 | -14.9% | 578,000 | 0.0% | 0.51% | -16.5% |
Q2 2021 | $45,096,000 | -5.6% | 578,000 | +14.5% | 0.61% | -14.4% |
Q1 2021 | $47,768,000 | -32.8% | 505,000 | -13.4% | 0.71% | -35.0% |
Q4 2020 | $71,039,000 | +112.3% | 583,000 | +52.2% | 1.09% | +66.3% |
Q3 2020 | $33,459,000 | +35.3% | 383,000 | 0.0% | 0.66% | +21.7% |
Q2 2020 | $24,738,000 | – | 383,000 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,737,297 | $176,802,000 | 6.75% |
MPM BioImpact LLC | 308,686 | $19,938,000 | 5.30% |
Burrage Capital Management LLC | 77,172 | $4,985,000 | 3.49% |
Orbimed Advisors | 2,745,327 | $177,321,000 | 2.50% |
Parkman Healthcare Partners LLC | 110,318 | $7,125,000 | 2.01% |
SECTORAL ASSET MANAGEMENT INC | 284,486 | $18,375,000 | 1.69% |
First Light Asset Management, LLC | 192,829 | $12,455,000 | 1.45% |
Asymmetry Capital Management, L.P. | 22,608 | $1,460,000 | 1.12% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,236,000 | 0.74% |
Prosight Management, LP | 25,602 | $1,654,000 | 0.71% |